Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-TEAM study of rituximab in adult-onset frequently relapsing or steroid-dependent nephrotic syndrome
jRCT2051200045Completed
- Sponsor
- Nippon Zenyaku Kogyo Co., Ltd.
- Start
- Sep 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in nephrosis comparing rituximab with placebo (2 arms). Primary endpoint: Recurrence-free period. Started Sep 2020; status: completed.
02
Drugs
rituximab
03
Conditions
nephrosis
Beyond the preview
Go deeper on jRCT2051200045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051200045.